Gastrointestinal

Aciloc 300 mg contains ranitidine, which reduces stomach acid production.

Aciloc 150 mg is an anti-ulcer medication containing ranitidine, widely used to treat acid-related disorders of the stomach and duodenum.

2. Pharmacological Class

• H2 receptor antagonist

• Anti-secretory drug

3. Mechanism of Action

Ranitidine competitively inhibits histamine at H2 receptors on gastric parietal cells.
This leads to:

• Reduced basal acid secretion

• Reduced nocturnal acid secretion

• Reduced acid secretion stimulated by food, histamine, insulin, caffeine, and gastrin

  Aciloc 150mg is an anti-ulcer medication containing ranitidine, widely used to treat acid-related disorders of the stomach and duodenum.

  ---

  2. Pharmacological Class

  • H2 receptor antagonist

  • Anti-secretory drug

  ---

  3. Mechanism of Action

  Ranitidine competitively inhibits histamine at H2 receptors on gastric parietal cells.
  This leads to:

  • Reduced basal acid secretion

  • Reduced nocturnal acid secretion

  • Reduced acid secretion stimulated by food, histamine, insulin, caffeine, and gastrin

    Aciloc 150 mg is an anti-ulcer medication containing ranitidine, widely used to treat acid-related disorders of the stomach and duodenum.

    ---

    2. Pharmacological Class

    • H2 receptor antagonist

    • Anti-secretory drug

    ---

    3. Mechanism of Action

    Ranitidine competitively inhibits histamine at H2 receptors on gastric parietal cells.
    This leads to:

    • Reduced basal acid secretion

    • Reduced nocturnal acid secretion

    • Reduced acid secretion stimulated by food, histamine, insulin, caffeine, and gastrin

      Aciloc 150mg is an anti-ulcer medication containing ranitidine, widely used to treat acid-related disorders of the stomach and duodenum.

      ---

      2. Pharmacological Class

      • H2 receptor antagonist

      • Anti-secretory drug

      ---

      3. Mechanism of Action

      Ranitidine competitively inhibits histamine at H2 receptors on gastric parietal cells.
      This leads to:

      • Reduced basal acid secretion

      • Reduced nocturnal acid secretion

      • Reduced acid secretion stimulated by food, histamine, insulin, caffeine, and gastrin

      It does not significantly affect gastric emptying or pancreatic secretion.

      Aciloc 150 mg is an anti-ulcer medication containing ranitidine, widely used to treat acid-related disorders of the stomach and duodenum.

      ---

      2. Pharmacological Class

      • H2 receptor antagonist

      • Anti-secretory drug

      ---

      3. Mechanism of Action

      Ranitidine competitively inhibits histamine at H2 receptors on gastric parietal cells.
      This leads to:

      • Reduced basal acid secretion

      • Reduced nocturnal acid secretion

      • Reduced acid secretion stimulated by food, histamine, insulin, caffeine, and gastrin

      It does not significantly affect gastric emptying or pancreatic secretion.

      Aciloc 300 mg is an anti-ulcer medication containing ranitidine, widely used to treat acid-related disorders of the stomach and duodenum.

      ---

      2. Pharmacological Class

      • H2 receptor antagonist

      • Anti-secretory drug

      ---

      3. Mechanism of Action

      Ranitidine competitively inhibits histamine at H2 receptors on gastric parietal cells.
      This leads to:

      • Reduced basal acid secretion

      • Reduced nocturnal acid secretion

      • Reduced acid secretion stimulated by food, histamine, insulin, caffeine, and gastrin

      It does not significantly affect gastric emptying or pancreatic secretion.

      Aciloc 150 mg is an anti-ulcer medication containing ranitidine, widely used to treat acid-related disorders of the stomach and duodenum.

      ---

      2. Pharmacological Class

      • H2 receptor antagonist

      • Anti-secretory drug

      ---

      3. Mechanism of Action

      Ranitidine competitively inhibits histamine at H2 receptors on gastric parietal cells.
      This leads to:

      • Reduced basal acid secretion

      • Reduced nocturnal acid secretion

      • Reduced acid secretion stimulated by food, histamine, insulin, caffeine, and gastrin

      It does not significantly affect gastric emptying or pancreatic secretion.

Pantosec LS Capsule is a combination medicine used for the treatment of acidity, GERD (gastro-esophageal reflux disease), heartburn, indigestion, and peptic ulcer. It contains Pantoprazole and Levosulpiride.

Rabesec DSR is a combination medicine used to treat acidity, gastro-esophageal reflux disease (GERD), and stomach ulcers. It contains Rabeprazole (a proton pump inhibitor that reduces stomach acid) and Domperidone (a prokinetic that improves stomach movement and prevents nausea).